This MedLibrary.org supplementary page on Follistatin is provided directly from the open source Wikipedia as a service to our readers. Please see the note below on authorship of this content, as well as the Wikipedia usage guidelines. To search for other content from our encyclopedia supplement, please use the form below:
Related Sponsors
| Follistatin | |
|---|---|
 The Structure Of The Follistatin:Activin Complex |
|
| Other names: | Follistatin, FSH-Suppressing Protein, Activin-binding protein |
| Genetic data | |
| Gene code: | HUGO code:FST |
| Protein Structure/Function | |
| Structure: | Follistatin:Activin Complex structure |
| Protein type: | Growth factor |
| Functions: | Regulates members of the TGF beta superfamily ligands |
| Domains: | 3 FOLN domains, 3 KAZAL domains |
| Other | |
| Taxa expressing: | Homo Sapiens; homologs: many metazoan phyla |
| Cell types: | many, placenta, blood, ovary, liver, testis |
| Subcellular localization: | extracellular |
| Molecular interactions: | Activin, inhibin, BMP5 |
| Medical/Biotechnological data | |
| Diseases: | polycystic ovary syndrome (PCOS) |
Follistatin is a single chain autocrine glycoprotein found to be ubiquitous within the body of nearly all higher animals, that is the product of a single gene.
It was initially isolated from follicular fluid and was identified as a protein fraction that inhibited Follicle-stimulating hormone (FSH) secretion from the anterior pituitary, and so was known as FSH-suppressing protein (FSP). Since then its primary function has been determined to be the binding and bioneutralization agent of members of the TGF-beta superfamily, with primary focus on Activin, a paracrine hormone (TGF-b member) which enhances secretion of FSH in the anterior pituitary.
Contents |
Biochemistry
It is part of the inhibin-activin-follistatin axis.
There are three known isoforms, FS-288, FS-300, and FS-315. Two are known to be created by alternative splicing of the primary mRNA transcript, FS-288 and FS-315. FS-300 (porcine follistatin) is thought to be the product of post-translational modification via truncation of the primary amino-acid chain.
Although FS is ubiquitous it's highest concentration has been found to be in the female ovary, followed by the skin.
In the tissues activin has a strong role in cellular proliferation, thereby making follistatin the safeguard against uncontrolled cellular proliferation and also allowing it to function as an instrument of cellular differentiation. Both of these roles are vital in tissue rebuilding and repair, and may account for follistatin's high presence in the skin.
In the blood, activin and follistatin are both known to be involved in the inflammatory response following tissue injury or pathogenic incursion. The source of follistatin in circulating blood plasma has yet to be determined, but due to its autocrine nature speculation suggests the endothelial cells lining all blood vessels, or the macrophages and monocytes also circulating within the whole blood.
Follistatin is involved in the development of the embryo. It has inhibitory action on bone morphogenic proteins (BMPs); BMPs induce the ectoderm to become epidermal ectoderm. Inhibition of BMPs allows neuroectoderm to arise from ectoderm, a process which eventually forms the neural plate. Other inhibitors involved in this process are noggin and chordin.
Follistatin and BMPs are also known to play a role in folliculogenesis within the ovary. The main role of follistatin in the oestrus/menstrus ovary, so far, appears to be progression of the follicle from early antral to antral/dominant, and importantly the promotion of cellular differentiation of the oestrogen producing granulosa cells (GC) of the dominant follicle into the progesterone producing large lutein cells (LLC) of the corpus luteum.
|
'
|
|
| Identifiers | |
| Symbol | FS/FST/FSP |
| Entrez | 10468 |
| HUGO | 3971 |
| OMIM | 136470 |
| RefSeq | NM_013409 |
| UniProt | P19883 |
| Other data | |
| Locus | Chr. 5 q11.2 |
Clinical significance
Follistatin is being studied for its role in regulation of muscle growth in mice, as an antagonist to myostatin (aka GDF-8, a TGF superfamily member) which inhibits excessive muscle growth. Lee & McPherron demonstrated that inhibition of GDF-8, either by genetic elimination (knockout mice) or by increasing the amount of follistatin, resulted in greatly increased muscle mass. [1][2]
It is also being investigated for its involvement in polycystic ovary syndrome (PCOS), though there is debate as to its direct role in this infertility disease.
References
- ^ Lee SJ, McPherron AC (2001). "Regulation of myostatin activity and muscle growth". Proc. Natl. Acad. Sci. U.S.A. 98 (16): 9306–11. doi:. PMID 11459935.
- ^ "'Mighty mice' made mightier". Retrieved on 2008-02-26.
External links
|
||||||||||||||||||||
|
|||||||||||||||||
 |
This molecular or cell biology article is a stub. You can help Wikipedia by expanding it. |
Wikipedia content modification information:
- This page was last modified on 4 October 2008, at 06:22.
Wikipedia Authorship and Review
Wikipedia content provided here is not reviewed directly by MedLibrary.org. Wikipedia content is authored by an open community of volunteers and is not produced by or in any way affiliated with MedLibrary.org.
Wikipedia Usage Guidelines
This article is licensed under the GNU Free Documentation License. It uses material from the Wikipedia article on "Follistatin".
The URL for this specific entry is:
All Wikipedia text is available under the terms of the GNU Free Documentation License. (See Copyrights for details). Wikipedia® is a registered trademark of the Wikimedia Foundation, Inc.